Explore a provisional 50-industry screening list and test CAGR scenarios. The original market ranges, growth rates and projections remain unverified research leads. The semiconductor and cybersecurity rows now include separately sourced historical baselines; the biopharmaceutical row includes broader prescription-medicine market context. Each has its own year, geography, definition and source. These additions do not validate the original estimates or make different market definitions comparable. Select a row to inspect the evidence and its limits. Categories and maturity labels are editorial classifications.
Understand the industry behind the numbers
Explore 6 scoped value-chain maps, business models, risks and source-backed evidence anchors. Coverage is a subset of the dataset.
- AI Software & Services
- Semiconductors
- Batteries & Energy Storage
- Cybersecurity
- Robotics
- Biopharmaceuticals
File updated September 2026. Added source records were reviewed on September 30, 2026; this is separate from the measurement year and publication date. Original numeric market sizes are in USD billions where available. Filters and scenarios still use the original indicative estimates, not the separately sourced baselines. The CAGR filter uses a range midpoint only when both bounds exist; a one-sided value is treated as a lower bound.
The full screening list is available below. Numeric coverage appears when the interactive controls load.
Full industry list
| Technology | Market ~2025 | ||||
|---|---|---|---|---|---|
| 1 | AI Software & Services Original ~2025 estimates unverified |
Large models / Agentic AI, Generative AI | ~$230–390B | 25%–35% | AI Foundation |
| 2 | Semiconductors Sourced baseline · 2025 Original ~2025 estimates unverified |
Advanced nodes (2nm/3nm), HBM, AI accelerators | ~$630–775B | 10%–18% | AI Foundation |
| 3 | Cloud Services Original ~2025 estimates unverified |
Hyperscale data centers, AI training/inference cloud | ~$220B baseline | 12%–17% | AI Foundation |
| 4 | Electric Vehicles (EVs) Original ~2025 estimates unverified |
Solid-state batteries, 800V platforms, domain controllers | ~$900–990B | 10%–15% | Energy |
| 5 | Batteries & Energy Storage Original ~2025 estimates unverified |
Solid-state, sodium-ion, flow batteries | ~$98B (batteries) | 12%–14% | Energy |
| 6 | Shared Autonomous Vehicles Original ~2025 estimates unverified |
L4/L5 autonomy, Robotaxi, vehicle-road coordination | Early stage | High (4%–20%) | Hard Tech |
| 7 | Space Economy Original ~2025 estimates unverified |
Reusable rockets, LEO constellations, satellite internet | ~$550–626B | 7%–10% | Hard Tech |
| 8 | Cybersecurity Sourced baseline · 2024 Original ~2025 estimates unverified |
Zero Trust, AI security, quantum-safe cryptography | ~$160–240B | 8%–20% | Digitization |
| 9 | Robotics (Industrial + Service) Original ~2025 estimates unverified |
Humanoid robots, collaborative robots, embodied AI | ~$50–90B | 14%–20% | Hard Tech |
| 10 | E-commerce Original ~2025 estimates unverified |
Social commerce, instant retail, cross-border platforms | Mature large-scale | 7%–9% | Digitization |
| 11 | Digital Advertising Original ~2025 estimates unverified |
Programmatic, AI targeting, retail media networks | ~$320–580B range | 8%–20% | Digitization |
| 12 | Streaming Video Original ~2025 estimates unverified |
Cloud gaming, interactive streaming, AI content | Mature growth | Mid-high | Digitization |
| 13 | Video Games Original ~2025 estimates unverified |
Cloud gaming, metaverse games, AI NPCs | Hundreds of $B | Mid-high | Digitization |
| 14 | Modular Construction Original ~2025 estimates unverified |
Prefabricated modules, digital construction | Early expansion | High | Manufacturing |
| 15 | Future Air Mobility Original ~2025 estimates unverified |
eVTOL, urban air mobility | Early commercialization | 10%–20% | Hard Tech |
| 16 | Obesity & Related Drugs Original ~2025 estimates unverified |
GLP-1 agonists, innovative weight-loss drugs | ~$24–100B range | 9%–35% | Bio & Health |
| 17 | Nuclear Fission Power Original ~2025 estimates unverified |
Small modular reactors (SMR), advanced reactors | ~$18B baseline | 7%–13% | Energy |
| 18 | Industrial & Consumer Biotech Original ~2025 estimates unverified |
Synthetic biology, enzyme engineering, bio-based materials | Early to growth | High | Bio & Health |
| 19 | Integrated Circuits (China focus) Original ~2025 estimates unverified |
Domestic advanced packaging, Chiplet, automotive chips | Rapid China growth | 20%+ | AI Foundation |
| 20 | Aerospace (China focus) Original ~2025 estimates unverified |
Domestic large aircraft, satellites, LEO constellations | Rapid expansion | High | Hard Tech |
| 21 | Biopharmaceuticals Sourced context · 2025 Original ~2025 estimates unverified |
Cell & gene therapy, antibody drugs, AI drug discovery | Mature high growth | 15%–25% | Bio & Health |
| 22 | Low-Altitude Economy Original ~2025 estimates unverified |
Drone logistics, eVTOL, low-altitude air traffic management | Early boom in China | 30%+ | Hard Tech |
| 23 | New-Type Energy Storage Original ~2025 estimates unverified |
Electrochemical, compressed air, flywheel storage | Rapid China growth | 25%+ | Energy |
| 24 | Intelligent Robots Original ~2025 estimates unverified |
Humanoid, industrial intelligent, service robots | Rapid expansion | High | Hard Tech |
| 25 | Quantum Technology Original ~2025 estimates unverified |
Quantum computing, communication, sensing | Early R&D / commercialization | High | AI Foundation |
| 26 | Bio-manufacturing Original ~2025 estimates unverified |
Synthetic bio-manufacturing, cell factories | Early | High | Bio & Health |
| 27 | Green Hydrogen Original ~2025 estimates unverified |
Water electrolysis, hydrogen trucks, green hydrogen chemicals | Early commercialization | High | Energy |
| 28 | Nuclear Fusion Energy Original ~2025 estimates unverified |
Tokamak, inertial confinement, demo reactors | R&D stage | Extremely high (long-term) | Energy |
| 29 | Brain-Computer Interface Original ~2025 estimates unverified |
Invasive / non-invasive BCI, neuromodulation | Early clinical / commercial | High | Bio & Health |
| 30 | Embodied AI Original ~2025 estimates unverified |
Multimodal models + robot bodies, physical-world interaction | Early breakout | Extremely high | Hard Tech |
| 31 | 6G Communications Original ~2025 estimates unverified |
Terahertz, integrated space-air-ground networks | R&D / standards | High (long-term) | Digitization |
| 32 | Data Centers & Computing Power Original ~2025 estimates unverified |
Liquid cooling, AI servers, intelligent computing centers | High-speed expansion | High | AI Foundation |
| 33 | Renewable Energy (Solar + Wind) Original ~2025 estimates unverified |
Perovskite cells, large offshore turbines, IBC modules | Large-scale mature | Mid-high | Energy |
| 34 | Hydrogen Full Value Chain Original ~2025 estimates unverified |
Green hydrogen production, storage/transport, fuel cells | Early to growth | High | Energy |
| 35 | CCUS Original ~2025 estimates unverified |
Carbon capture, utilization, geological storage | Early | High | Energy |
| 36 | Smart Manufacturing / Industry 4.0 Original ~2025 estimates unverified |
Digital twins, industrial AI, flexible production lines | ~$550–650B (2025) | ~19% | Manufacturing |
| 37 | Fintech Original ~2025 estimates unverified |
Digital payments, embedded finance, blockchain settlement | Mature high growth | Mid-high | Digitization |
| 38 | Silver Economy / Smart Elderly Care Original ~2025 estimates unverified |
Age-friendly products, telemedicine, rehab robots | Rapid China growth | 15%–20% | Bio & Health |
| 39 | Gene & Cell Therapy Original ~2025 estimates unverified |
CRISPR gene editing, CAR-T, stem-cell therapy | Rapid commercialization | 20%+ | Bio & Health |
| 40 | Synthetic Biology Original ~2025 estimates unverified |
Genetic circuit design, microbial cell factories | Early expansion | High | Bio & Health |
| 41 | Advanced Materials Original ~2025 estimates unverified |
Graphene, superconducting materials, next-gen semiconductors | Early to growth | High | Manufacturing |
| 42 | Satellite Internet Original ~2025 estimates unverified |
LEO constellations, high-throughput satellite communications | Rapid deployment | High | Hard Tech |
| 43 | Autonomous Driving & Connected Vehicles Original ~2025 estimates unverified |
LiDAR, domain controllers, vehicle-road-cloud integration | Growth stage | High | Hard Tech |
| 44 | Medical AI & Digital Health Original ~2025 estimates unverified |
AI diagnosis, telemedicine, wearable monitoring | Rapid expansion | High | Bio & Health |
| 45 | Green Buildings & Energy Efficiency Original ~2025 estimates unverified |
BIPV, smart building systems | BIPV ~$17B (2024) | ~20% | Manufacturing |
| 46 | Logistics Automation & Drone Delivery Original ~2025 estimates unverified |
Warehouse robots, last-mile delivery drones | Rapid expansion | High | Manufacturing |
| 47 | Digital Twin & Industrial Metaverse Original ~2025 estimates unverified |
Factory digital twins, virtual-physical simulation | Early to growth | High | Manufacturing |
| 48 | Privacy Computing & Data Elements Original ~2025 estimates unverified |
Federated learning, multi-party computation, data trading | Early expansion | 20%+ | Digitization |
| 49 | Advanced Connectivity Original ~2025 estimates unverified |
5G-Advanced, 6G, space-air-ground-sea integration | 5G mature, 6G R&D | High | Digitization |
| 50 | Sustainable Food & Alternative Proteins Original ~2025 estimates unverified |
Cultured meat, plant-based proteins, precision fermentation | Early commercialization | High | Bio & Health |
Source review notes
The original screening estimates are unchanged. The following records are shown separately so their boundaries remain visible:
| Industry row | Sourced figure | What it establishes |
|---|---|---|
| Semiconductors | USD 795.6 billion in 2025 | Annual semiconductor product sales in WSTS’s March 6, 2026 release. This is above the original screening range and does not establish its CAGR or forecast. |
| Cybersecurity | USD 193.408 billion in 2024 | Gartner’s historical estimate of worldwide information security end-user spending, from its July 29, 2025 release. The source’s later-year numbers are forecasts. End-user spending is not necessarily vendor revenue. |
| Biopharmaceuticals | USD 1,667.671 billion in 2025 | Broader global prescription-medicine sales at ex-manufacturer prices, reported by EFPIA / IQVIA MIDAS, Key Data 2026, page 14. Includes medicines beyond biological products and does not measure the biopharmaceutical-only market. |
The downloadable CSV includes separate baseline_* columns for these records. Empty original-source fields still mean the original estimate has not been verified. A sourced baseline or broader-market context is not a forecast validation.